Skip to main content
. 2015 Aug 5;16(8):18077–18095. doi: 10.3390/ijms160818077

Figure 2.

Figure 2

(a) Kaplan Meier plot for overall survival in patients with diffuse large B-cell lymphoma (DLBCL) (n = 58) stratified by miR-199a expression level. The black dotted line represents patients with high miR-199a expression levels; (b) Kaplan Meier plot for overall survival in patients with DLBCL (n = 58) stratified by miR-497 expression level. The black dotted line represents patients with high miR-497 expression levels; (c) Kaplan Meier plot for overall survival in patients with DLBCL (n = 58) stratified by miR-199a and miR-497 expression levels. The black dotted line represents patients with high miR-199a and high miR-497 expression levels; (d) Kaplan Meier plot for overall survival in patients with DLBCL (n = 55) stratified by their Immunohistochemistry (IHC) profile; (e) Kaplan Meier plot for overall survival in patients with DLBCL (n = 58) stratified by their IHC profile combined with miR-199a and miR-497 expression levels; (f) Kaplan Meier plot for overall survival in patients with DLBCL, germinal center subtype (GCB) (n = 38) stratified by miR-199a and miR-497 expression level. The black dotted line represents patients with high miR-199a and miR-497 expression levels.